Articles related to ALZHEIMER'S/DEMENTIA

Accelerometer-derived sleep-wake cycle metrics independently predicted incident dementia in 53,448 UK Biobank participants, with predictive improvement comparable to APOE genotype contribution when added to age-only models.

Brain-predicted age difference and socioeconomic status moderated the relationship between AD pathology markers and cognitive performance in a cross-sectional cohort of 621 cognitively unimpaired older adults.

A clinician review outlined how diagnostic confidence, staging, genetic risk, and imaging features inform patient selection for amyloid-targeting Alzheimer’s therapies.

Falls are considered a nurse-sensitive incident because fall prevention is impacted by the quantity and quality of nursing care.

Blarcamesine (Anavex 2-73), an investigational once-daily oral autophagy enhancer, showed sustained cognitive, functional, and brain volume benefits through nearly 3 years in a Phase 2b/3 trial and open-label extension presented at AD/PD 2026.

A retrospective ADNI cohort analysis found that omega-3 supplement users showed faster cognitive decline over 5 years than matched non-users, with FDG-PET evidence of reduced brain glucose metabolism.